KEKirsten D. Erickson

Kirsten D. Erickson

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kirsten D. Erickson has a total of 5 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Identifying patients for clinical trials: Evaluation of NCI-designated community cancer centers.

    by Christine B. Mackay, Kerry Hepler, Kirsten D Erickson, Christine Daley

    E18174 Background: The University of Kansas Cancer Center achieved NCI designation in 2012, and the year prior, acquired 5 outpatient cancer clinics, which contributed to nearly a doubling of the tumor registry cases. Prior to this merger, these practices were part of one of the nation’s largest site management organization networks of community-based oncology practices and were consistently listed as top accruing sites for many of the trials that were conducted. Soon after the merger, clinical trial enrollment dropped significantly, providing a unique opportunity to analyze the reasons for this drastic change in accrual patterns. The primary aim of this study was to identify what factors influence how patients are identified for possible clinical trial participation. Methods: This was a cross-sectional qualitative design. Individual interviews were conducted with 27 physicians and nurse practitioners. Six focus groups included 26 clinical and research staff. Descriptive summary statistics and standard text analysis were performed to summarize responses. Results: The top three factors reported to affect patient identification included: 1) absence of research staff in the clinic, 2) low physician engagement in the clinical trial process, and 3) a general lack of awareness of clinical trials by providers, clinic and research staff. 100% of the providers interviewed agreed that clinical trials are beneficial for patients as well as the practice, and most (98%) agreed the physician is primarily responsible for patient identification. Conclusions: The results from this project support the literature which suggests that physicians are the most significant factor in successful recruitment of patients to cancer clinical trials but adequate organizational support is necessary. Centers considering expanding their network to include community locations should be aware of how organizational changes may affect physician ability to accrue.

  • Open Access

    Clinical trial insurance coverage for cancer patients under the Affordable Care Act

    by Christine B. Mackay, Tami Gurley-Calvez, Kirsten D. Erickson, Roy A. Jensen